Group 1 (acute paralysis group) |
1 | 37/M | Pharyngitis | + | – | – | – | GM1/GM2 (IgG) |
2 | 18/M | Pharyngitis | + | – | – | – | GT1a (IgG) |
3 | 46/M | Colitis | + | – | – | – | GD1a (IgG) |
| | | | | | | GM1/GD1a/GT1b(IgM) |
4 | 20/M | None | + | – | – | – | GT1b (IgG) |
5 | 51/M | Colitis | + | – | – | – | GM1 (IgG) |
Group 2 (acute ataxia and ophthalmoplegia group) |
6 | 48/M | None | – | + | + | VII | GM1/GalNAc-GD1a/GT1b (IgG) |
7 | 41/F | Pharyngitis | – | + | + | – | GQ1b (IgG) |
8 | 21/F | Colitis | – | + | + | – | GQ1b (IgG) |
9 | 30/F | None | – | + | + | – | GQ1b (IgG) |
10 | 57/F | Pharyngitis | – | + | + | – | GQ1b (IgG) |
11 | 48/F | None | – | + | + | – | GalNAc-GD1a (IgG) |
12 | 74/F | None | – | + | + | – | GQ1b (IgG) |
Group 3 (chronic paralysis with conduction block group) |
13 | 57/M | None | + | – | – | IX–XII | GM1/GD1b (IgM) |
14 | 49/M | None | + | – | – | – | GM1 (IgM) |
| | | | | | | |
GBS | | | | | | | |
1 | 33/M | None | + | – | – | – | GM1 (IgG) |
2 | 24/F | Colitis | + | – | – | V, VII, IX–XII | GM1b/GD1b (IgG) |
3 | 23/M | Pharyngitis | + | – | – | – | GM1/GT1b (IgG) |
4 | 14/M | Colitis | + | – | – | – | GM1/GT1b (IgG) |
5 | 46/M | Pharyngitis | + | – | – | – | GM1b (IgG) |
6 | 58/F | None | + | – | – | – | GM2 (IgG) |
7 | 33/F | Pharyngitis | + | – | – | – | GM1b/GD1b (IgG) |
MFS | | | | | | | |
1 | 73/F | Pharyngitis | – | + | + | – | GQ1b (IgG) |
2 | 60/F | Pharyngitis | – | + | + | – | GM1/GM2/LM1 (IgG) |
3 | 32/F | Pharyngitis | – | + | + | – | GQ1b (IgG) |
4 | 74/M | None | – | + | + | – | GM1 (IgM) |
5 | 75/F | Pharyngitis | – | + | + | – | GQ1b/GT1a (IgG) |
6 | 59/F | Pharyngitis | – | + | + | – | – |
7 | 80/F | Pharyngitis | – | + | + | – | GQ1b (IgG) |
8 | 25/M | Pharyngitis | – | + | + | – | GQ1b/GT1a (IgG) |
MMN | | | | | | | |
1 | 51/M | None | + | – | – | – | GM1 (IgM) |
2 | 63/F | None | + | – | – | – | – |
3 | 43/F | None | + | – | – | – | GM1/GD1b (IgM) |
4 | 66/M | None | + | – | – | – | GM1 (IgM) |
5 | 51/F | None | + | – | – | – | GM1 (IgM) |
6 | 58/F | None | + | – | – | – | – |